Clinical Trials Logo

Liver Neoplasms clinical trials

View clinical trials related to Liver Neoplasms.

Filter by:

NCT ID: NCT01612325 Completed - Liver Neoplasms Clinical Trials

Radioactive Holmium Microspheres for the Treatment of Unresectable Liver Metastases

HEPAR-2
Start date: May 2012
Phase: Phase 2
Study type: Interventional

Radioembolisation is a known method for the treatment of liver tumors and or livermetastases. Currently small beadlets called microspheres are used that are loaded with the beta radiation emitting Yttrium-90. Holmium-166 microspheres have different physical characteristics including good visualisation in gammacameras due to the gamma emission. Because of the higher specific activity higher radiation doses to the liver will be used compared to the standard Yttrium treatment. It is hypothesized that higher doses of irradiation have an improved antitumor effect.

NCT ID: NCT01596283 Completed - Liver Cancer Clinical Trials

Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection

Start date: April 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to help us learn what is the best amount of fluid to administer to patients during liver surgery. Patients will receive either an amount for this surgery based on weight, blood pressure, heart rate and urine output or an amount guided by a computerized system (FloTrac) that helps doctors know how much fluid each patient needs. The FloTrac calculates the amount of fluid patients needs on a minute-to-minute basis, based on real time information like blood pressure, pulse and the ability of the heart and blood vessels to maintain normal vital signs.

NCT ID: NCT01595243 Completed - Clinical trials for Hepatocellular Carcinoma

Effects of Telephone Consultations on Discharged Liver Cancer

Start date: October 2009
Phase: N/A
Study type: Interventional

The aims of this three-year study are to: 1. From patients and family perspective to explore the needs for home care after receiving TACE, PEI, and RFA 2. Develop a telephone follow-up and consultation program and examine its effect on self-efficacy, anxiety, depression and quality of life in liver cancer patients receiving non-surgical treatment.

NCT ID: NCT01581307 Completed - Pancreatic Cancer Clinical Trials

Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets

Start date: April 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and impact on survival with treatment with 90-Y glass microspheres in conjunction with leucovorin, 5-fluorouracil (5-FU) and oxaliplatin (FOLFOX) as second-line treatment with in patients gemcitabine-refractory metastatic pancreatic cancer with predominantly liver metastases.

NCT ID: NCT01565811 Completed - Clinical trials for Colorectal Cancer With Liver Metastasis

Prospective Phase II Trial on Prophylactic Perihepatic Lymphadenectomy in Patients With Colorectal Cancer With Liver Metastasis

LN
Start date: August 2010
Phase: Phase 2
Study type: Observational

Objective: To evaluate the role of regional lymphadenectomy in patients with colorectal cancer liver metastasis. Background: Lymph node status is 1 of the most important prognostic factors in oncologic surgery; however, the role of lymph node dissection remains unclear for colorectal cancer liver metastasis.

NCT ID: NCT01545804 Completed - Liver Cancer Clinical Trials

Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma

Start date: August 2011
Phase: Phase 2
Study type: Interventional

This is a single-arm, open-label phase II trial. Eligible patients must have histological or clinical diagnosis of Hepatocellular Carcinoma (HCC), advanced tumors that are not amenable to loco-regional therapy, documented progression with or intolerance to sorafenib-based treatment or other anti-angiogenic therapy as first-line therapy for advanced HCC.

NCT ID: NCT01539993 Completed - Liver Cancer Clinical Trials

Prospective Liver Study

Start date: November 2008
Phase: N/A
Study type: Observational

This study is designed for patients diagnosed with Liver cancer to collect information about the relationship between types of liver cancer, methods of treatment and outcomes over time.

NCT ID: NCT01528878 Completed - Colonic Neoplasms Clinical Trials

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Start date: April 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine a tolerable dose of radiation delivered by the CyberKnife system in two groups of patients with hepatocellular carcinoma (HCC).

NCT ID: NCT01526200 Completed - Clinical trials for Colon Cancer Liver Metastasis

Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases

CEIOUSCLM
Start date: October 2007
Phase: N/A
Study type: Observational

Contrast-enhanced intraoperative ultrasound (CE-IOUS) during surgery for colorectal liver metastases (CLM) has become a part of clinical practice. However, if it should be selectively or routinely applied remains unclear. This study is carried out to clarify which are the criteria for a selective use of CE-IOUS if any.

NCT ID: NCT01523353 Completed - Colorectal Cancer Clinical Trials

Prehabilitation in Liver Surgery

Start date: July 2011
Phase: Phase 1
Study type: Interventional

Each year in the UK around 1500 patients undergo surgery for bowel cancer that has spread to the liver. This is major surgery that offers a chance of cure, but can be associated with complications. Fitter patients are less likely to have serious complications. We are interested in finding out whether a short exercise program can improve patient fitness before surgery and whether this can reduce surgical complications. We plan to measure the fitness of patients who are going to have liver surgery. We will then give them an exercise programme for 4 weeks, after which we will assess their fitness again. We are also interested in whether fitter people have better Liver function. To assess this we will take a small sample of liver tissue during the operation for laboratory analysis of its function. Hypothesis 1. A short period of exercise can significantly improve fitness prior to liver surgery 2. Greater Fitness is associated with better liver function.